Medtronic Plc

Medtronic Plc

MDT

Market Cap$119.01B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Medtronic PlcMedtronic Plc27.83.01%9%3.40.6

Earnings Call Q2 2025

November 19, 2024 - AI Summary

Quarterly Performance and Growth: Medtronic reported a strong Q2 with a 5% organic revenue growth and an 8% EPS growth on a constant currency basis. This marks the eighth consecutive quarter of mid-single-digit organic revenue growth. The company is on track to deliver high single-digit EPS growth in the second half of the fiscal year, projecting fiscal '25 organic revenue growth between 4.75% to 5%.
Strong Performance Across Segments: Notable segment performances included double-digit growth in Diabetes (up 11%) and high single-digit growth in Cardiac Ablation Solutions and Neuroscience (both around 8%). The Structural Heart segment saw strong performance due to the TAVR franchise and new product launches.
Challenges and Supply Chain Issues: Specific challenges were faced in the Cardiac Ablation Solutions segment due to a third-party component supplier interruption. However, this issue has been resolved, and capacity is expected to ramp up, allowing for strong double-digit growth in Q3. Cryoablation technology continues to see declines, though the rate of decline has improved sequentially.

Exclusive for Stockcircle Pro members

Sign upSign Up
$93.00

Target Price by Analysts

8% upsideMedtronic Plc Target Price DetailsTarget Price
$98.38

Current Fair Value

14.3% upside

Undervalued by 14.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$119.01 Billion
Enterprise Value$146.89 Billion
Dividend Yield$2.79 (3.00614157957117%)
Earnings per Share$2.77
Beta0.85
Outstanding Shares1,282,400,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio27.76
PEG69.89
Price to Sales3.44
Price to Book Ratio2.33
Enterprise Value to Revenue4.45
Enterprise Value to EBIT38.99
Enterprise Value to Net Income34
Total Debt to Enterprise0.2
Debt to Equity0.6

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Medtronic Plc

CEO: Geoffrey Martha